Re: Trial delay
|
5
|
Resverlogix Corp.
|
May 04, 2021 08:55PM
|
Re: A message from Kelsee.....
|
5
|
Resverlogix Corp.
|
Oct 29, 2021 02:45PM
|
Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
|
5
|
Resverlogix Corp.
|
Dec 22, 2020 10:08AM
|
Opportunity continues to knock
|
5
|
Resverlogix Corp.
|
Aug 13, 2024 07:45AM
|
Pfizer
|
5
|
Zenith Epigenetics
|
Mar 11, 2024 07:39AM
|
While we fiddle
|
5
|
Resverlogix Corp.
|
Jul 20, 2023 08:10AM
|
Re: Too good "to be allowed" to be true?
|
5
|
Resverlogix Corp.
|
Jan 01, 2018 11:16AM
|
Re: Shake it Up!
|
5
|
Resverlogix Corp.
|
Dec 24, 2020 01:12PM
|
Re: Zenith Epigenetics Corp. Commences Operations
|
5
|
Zenith Epigenetics
|
Dec 08, 2015 08:18PM
|
Re: AGM Voting
|
5
|
Zenith Epigenetics
|
Oct 16, 2022 07:13PM
|
Re: To good to be true?
|
5
|
Resverlogix Corp.
|
Nov 01, 2021 07:11AM
|
Cystic Fibrosis breakthrough
|
5
|
Resverlogix Corp.
|
Nov 04, 2019 07:08PM
|
Re: Resverlogix Announces a Favorable Outlook Based on New Cardiovascular Disease Treatment Guidelines for Patients with Type 2 Diabetes
|
5
|
Resverlogix Corp.
|
Aug 29, 2023 06:49PM
|
Re: The Old Boy Who Cried Wolf
|
5
|
Resverlogix Corp.
|
Sep 19, 2020 08:47PM
|
Re: Q1- March 31, 2022 on SEDAR
|
5
|
Resverlogix Corp.
|
May 22, 2022 08:45PM
|
The crick didn’t rise, here’s the presentation, finally!
|
5
|
Zenith Epigenetics
|
Oct 27, 2023 05:31PM
|
Re: I have not....
|
5
|
Resverlogix Corp.
|
Dec 12, 2019 04:36PM
|
Zenith News
|
5
|
Zenith Epigenetics
|
Sep 21, 2021 08:13AM
|
Re: Objectivity requires facts....we don't have them all yet
|
5
|
Resverlogix Corp.
|
May 15, 2019 11:31PM
|
Re: Time keeps ticking
|
5
|
Resverlogix Corp.
|
Nov 18, 2021 08:22PM
|